Sponsor Dossier
Sandoz
Sponsor Dossier for Sandoz. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABIRATERONE SANDOZ
- Brand: ACICLOVIR SANDOZ
- Brand: ACLASTA
- Brand: AFONAISE
- Brand: AFQLIR
- Brand: ALENDRONATE
- Brand: ALLOPURINOL SANDOZ
- Brand: ALPRAZOLAM SANDOZ
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
- Device (sponsor): Basic growth hormone pen, replaceable-cartridge
About
Sandoz is an Australian Private Company with ABN 60075449553, registered in NSW and currently active.
Portfolio
Sandoz maintains a portfolio of 203 brands on the ARTG, of which 171 have cleared the SEO quality gate for indexing. 165 brands have Product Information on file, 45 are PBS-listed, 25 have PBAC outcomes on record, and 9 have AusPARs on record.
Therapeutic focus
— Neurology: 40 brands — Oncology: 39 brands — Infectious Disease: 28 brands — Cardiology: 27 brands — Endocrinology: 12 brands — Ophthalmology: 8 brands — Immunology: 7 brands — Haematology: 7 brands — Pain & Anaesthesia: 7 brands — Respiratory: 7 brands — Urology: 7 brands — Gastroenterology: 7 brands
PBS footprint
Sandoz has 45 brands with at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
Sandoz recorded its latest PBAC outcome on 1 July 2025, with 25 brands holding PBAC outcomes on record. The latest AusPAR was issued on 15 May 2025, with 9 brands holding AusPARs on record.